ONTO INNOVATION INC. Earnings Summary — Q1 2026
Onto Innovation Hits Record $292M Revenue Amid Advanced Packaging Surge
Key Takeaways
- Revenue reached $291.95M, representing a 9.5% YoY growth and strong momentum in advanced packaging segments.
- Net income recovered sharply on a QoQ basis ($33.75M vs $10.53M) after a weaker results period in Q4 2025.
- Operating expenses remain high at $112.88M, driven by increased R&D and G&A to support AI-related tool development.
- The balance sheet remains exceptionally strong with zero long-term debt and significant cash reserves.
- YoY Net Income growth is negative (-47%) primarily due to a very high tax provision and increased depreciation and amortization.
- Management is successfully pivoting the company toward 'Connected Intelligence' and high-end AI lithography tools.
- The company continues to gain market share in semiconductor inspection despite intense competition from larger peers.
Management Guidance
Management is focused on scaling for AI chip manufacturing, anticipating continued growth in advanced packaging and heterogeneous integration tools.
Sentiment Shift
Improving
Revenue and net income have pivoted back into growth territory following a cyclical dip in late 2025, suggesting a new expansion phase tied to AI infrastructure.
Outlook
The outlook remains strong as the company is positioned as a powerhouse in process control for advanced semiconductor nodes and AI-centric chipsets.
From the Annual Report (Key Quotes)
“The company has demonstrated a parabolic growth trajectory, with revenues scaling from $324M in 2018 to over $1B in 2024.”
“Management has successfully integrated the merger, transitioning from a cyclical small-cap to a high-margin, compounding mid-cap leader.”
“Superior positioning in advanced packaging and front-end wafer inspection are critical for AI chip manufacturing.”
Official Quarterly Documents
This summary is AI-generated from ONTO INNOVATION INC.'s latest quarterly filing and earnings call. For informational purposes only — not investment advice.